Somnus Therapeutics, Inc.
Insomnia Therapeutics
Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia Somnus Therapeutics Somnus Therapeautics Insomnia Somnus Therapeutics Insomnia Product Somnus Therapeautics Insomnia Insomnia Information from Somnus Therapeutics Somnus Therapeautics Insomnia Somnus Therapeutics News and Events Somnus Therapeautics Insomnia Contact the Insomnia Specialists Somnus Therapeutics Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia
  overview
Somnus Therapeutics Insomnia
  about
Somnus Therapeutics Insomnia
  sleep & insomnia
Somnus Therapeutics Insomnia
  press releases
Somnus Therapeutics Insomnia
  information
Somnus Therapeutics Insomnia
  management
 
  publications
  directions
  board of directors
  research presentations
  scientific advisors
         

Lorenzo Pellegrini, PhD, Partner, Care Capital

  • Post-Doctoral research fellow, Department of Cell Biology, Yale University, investigating the molecular basis of neuronal signaling and receptor internalization.
  • Ten years as academic scientist, published original research in leading peer-reviewed journals including, Nature, Cell and Neuron; awards including EMBO and Howard Hughes Medical Institute fellowships.
  • Laurea in Chemistry, summa cum laude, University of Padova, Italy; PhD Biochemistry from Max-Planck-Institute for Brain Research, Frankfurt am Main, Germany; MBA with Honors, The Wharton School of the University of Pennsylvania

 


 
Somnus Therapeautics Insomnia
Somnus Therapeautics Insomnia